"Despite this, many breast cancer patients stop taking their aromatase inhibitor treatment —which is usually prescribed for five years — or do not adhere to their treatment prescription," she said, adding that this may be due to, at least in part, the side effects associated with the drugs...
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them. December 18th 2024 ...
Breast cancer treatments that could cause hair loss include chemo, radiation, hormonal therapy, and targeted therapy. Not everyone will lose their hair during cancer treatment. It depends on the type of treatment and the dose. Your doctor can tell you if you can expect hair loss. Talk to the...
Endocrine therapy of metastatic breast cancer has been established for more than a century. Following the discovery of the beneficial effects of oophorectomy by Beatson in 1896 and the identification of the first estrogen receptor (ER- ) by E. Jensen 70 years later (1967), antihormonal ...
Despite the excellent results obtained with hormone therapy, the long treatment period and the side effects associated with its use make patient adherence difficult. Moreover, certain aspects of health care can mitigate or exacerbate non-adherence. This
Everolimus Added To Hormonal Therapy Postpones Disease Progression In Advanced Breast CancerWomen with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) metastatic who have previously received an aromatase inhibitor have slower disease progression when everolimus is ...
Hormonal treatment of breast cancer has been revisited during the last few years. New drugs have been introduced and shown to improve patient outcome, both with regard to efficacy and side effects. Historical aspects and newer developments are presented. New drugs such as second- and third-generat...
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival : an overview of the randomised trials EBCTC Group - 《Lancet》 被引量: 8701发表: 2005年 Systemic Treatment of Early Breast Cancer by Hormonal, Cytotoxic, or Immune Therapy &NA - 《...
RGD engineered dendrimer nanotherapeutic as an emerging targeted approach in cancer therapy 2021, Journal of Controlled Release Citation Excerpt : There are several treatment options to treat breast cancer, for instance, radiotherapy, immunotherapy, chemotherapy, hormonal therapy and surgery, but chemotherapy...
In women with advanced breast cancer(处于 进展期乳腺癌的妇女), chemo 33、therapy can help control the cancers growth(化疗可以 帮助控制肿瘤的生长). Side effects(副作用) may include hair loss(脱发), nausea (ns; -z-)(恶心), fatigue (疲劳), and a higher risk of infection(更易受细菌感染)...